Blockchain Registration Transaction Record

Chronic Inflammation Identified as Key Driver of Long Covid

New research identifies chronic inflammation as the key driver of long Covid, affecting 15 million Americans. This breakthrough opens new treatment pathways and impacts companies like Soligenix Inc.

This discovery represents a major breakthrough in understanding long Covid, which affects approximately 15 million Americans with debilitating symptoms that can persist for months or years. By identifying chronic inflammation as the primary mechanism, researchers can now develop targeted treatments that address the root cause rather than just managing symptoms. This could lead to effective therapies that restore quality of life for millions suffering from this condition, potentially reducing healthcare costs and economic impacts from lost productivity. The findings also validate ongoing research into inflammation-related treatments and provide a clearer direction for future medical interventions.